Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Interactive Voice Response (IVR) for Methadone Patients
This study has been completed.
Sponsored by: Rhode Island Hospital
Information provided by: Rhode Island Hospital
ClinicalTrials.gov Identifier: NCT00237406
  Purpose

This study is designed to test whether a telephone call-in program is a feasible way to collect mood and drug-related information in individuals enrolled in a methadone maintenance program.


Condition Intervention Phase
Opioid-Related Disorders
Procedure: interactive voice response
Phase III

Drug Information available for: Methadone Methadone hydrochloride
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Interactive Voice Response for Methadone Patients

Further study details as provided by Rhode Island Hospital:

Estimated Enrollment: 50
Study Start Date: January 2006
Study Completion Date: October 2006
Detailed Description:

Participants will complete a baseline interview and a follow-up interview at 5-weeks post-baseline. Two-thirds of the participants will be randomized into the telephone call-in group, and will be asked to complete daily, 10-minute, telephone interviews. To complete these interviews, participants will call into a toll-free telephone interview system with a unique and private Study ID number, and answers questions by using the telephone key pad. Questions during both the face-to-face interviews and the telephone interviews will assess mood, sleep, treatment utilization and drug-related experiences. Participants will be compensated for their time.

Comparison(s): Participants randomized into the telephone component of the study as compared to participants in the interview-only component of the study.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Recent enrollment in a methadone maintenance program

Exclusion Criteria:

  • Enrollment in a methadone maintenance program within the prior 3 months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00237406

Locations
United States, Rhode Island
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Rhode Island Hospital
Investigators
Principal Investigator: Michael D Stein, MD Rhode Island Hospital
  More Information

Study ID Numbers: 4065-05
Study First Received: October 11, 2005
Last Updated: December 17, 2007
ClinicalTrials.gov Identifier: NCT00237406  
Health Authority: United States: Institutional Review Board

Keywords provided by Rhode Island Hospital:
IVR, methadone
methadone maintenance

Study placed in the following topic categories:
Naphazoline
Oxymetazoline
Methadone
Guaifenesin
Phenylephrine
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin
Phenylpropanolamine
Opioid-Related Disorders

Additional relevant MeSH terms:
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Analgesics
Antitussive Agents
Central Nervous System Agents
Analgesics, Opioid
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009